Telmisartan And Amlodipine Tablet
Product Images NDC 46708-187

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Telmisartan And Amlodipine (NDC 46708-187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

40 mg 10 mg 80's Carton (Telmiamlo 4010mg)

Packaging label for Telmisartan and Amlodipine Tablets, strength 40 mg/10 mg, manufactured by Alembic Pharmaceuticals Limited. The label indicates an 80-tablet count, packaged as 10 blister cards of 8 tablets each. It includes the NDC 46708-185-08 and states Rx only. The design features a green and white color scheme with the strength prominently displayed multiple times.*

FDA Label Image

40 mg 5 mg 80's Carton (Telmiamlo 405mg)

Flat layout of a carton for Telmisartan and Amlodipine Tablets, 40 mg/5 mg strength. The label shows the product name prominently on multiple sides with dosage strength clearly marked as 40 mg/5 mg. The packaging contains 80 tablets packaged in 10 blister cards of 8 tablets each. The labeler is Alembic Pharmaceuticals Limited. Additional text includes NDC 46708-184-08 and Rx only, with storage and batch information areas visible.*

FDA Label Image

80 mg 10 mg 60's Carton (Telmiamlo 8010mg)

Packaging label for Telmisartan and Amlodipine Tablets, 80 mg/10 mg strength. The label includes product name, strength, and quantity details: 60 tablets in 10 blister cards of 6 tablets each. The labeler is Alembic Pharmaceuticals Limited. The packaging shows the NDC 46708-187-06 and features the Alembic logo.*

FDA Label Image

80 mg 5 mg 60's Carton (Telmiamlo 805mg)

Packaging label for Telmisartan and Amlodipine Tablets, 80 mg/5 mg, manufactured by Alembic Pharmaceuticals Limited. The package contains 60 tablets, divided into 10 blister cards with 6 tablets each. The label includes the product name, strength, dosage form as tablets, and a barcode. The label also states 'Rx only' and displays the NDC 46708-186-06.*

FDA Label Image

Structure (Telmiamlo Amlo)

Chemical structure diagrams showing two distinct molecules, likely representing the active ingredients in the product Telmisartan and Amlodipine. The left structure features a complex ring with chlorine and ester groups, while the right structure displays a benzene ring with a sulfonic acid group (SO3H).*

FDA Label Image

Figure (Telmiamlo Figure)

Four line graphs displaying probabilities of achieving target blood pressure levels at Week 8. The top left graph shows the probability of achieving systolic blood pressure under 140 mmHg, the top right under 130 mmHg. The bottom left graph presents the probability of achieving diastolic blood pressure under 90 mmHg, and the bottom right under 80 mmHg. Each graph plots probabilities against baseline blood pressure values for different treatment groups, including Telmisartan and Amlodipine combination and placebo.*

FDA Label Image

Peal (Telmiamlo Peal)

An instructional illustration showing hands opening a blister pack to remove an oral tablet. The image demonstrates the proper way to peel back the foil backing from the blister to access a tablet inside.*

FDA Label Image

Tear (Telmiamlo Tear)

An instructional illustration showing a hand pushing a tablet through the foil of a blister pack. The image demonstrates how to properly remove an oral tablet from its packaging by pressing through the foil backing.*

FDA Label Image

Structure (Telmiamlo Telmi)

Chemical structure of Telmisartan and Amlodipine shown as a connected molecular diagram with labeled chemical groups including rings, methyl groups, and carboxyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.